A critical voice in the Clinical Trials sector in Australia will be represented on the executive committee through Medicines Australia.
Medicines Australia represents the discovery-driven pharmaceutical industry in Australia. They represent the innovative medicines industry by engaging with all other stakeholders and have a mission to “drive the creation and development of a predictable environment for the continued, sustainable growth of the innovative and research based prescription medicines industry so Australians continue to lead longer and healthier lives.”
